Biomatics Capital Partners


Biomatics Capital is a healthcare-focused venture firm that invests in companies at the intersection of genomics and digital data. The firm supports companies across areas including gene editing and DNA synthesis and positions itself as an active partner providing capital, strategic advising and connections to domain experts.

Industries

biotechnology
health-care
life-science
venture-capital-b37d

Nr. of Employees

small (1-50)

Biomatics Capital Partners

Seattle, Washington, United States, North America


Portfolio

Referenced on Biomatics homepage and in multiple portfolio media coverage entries about DNA data storage and sequencing.

#DNA synthesis / synthetic biology

Covered in press items including a reported acquisition by Exact Sciences (press coverage listed on site).

#Liquid biopsy / diagnostics

Multiple media stories listed on Biomatics site covering AI in healthcare and medication adherence studies.

#AI-enabled digital health / medication adherence

Press coverage includes clinical progress and funding announcements (listed on site).

#Neurobehavioral therapeutics / neuroscience

Multiple media items covering financing and technology noted on the site.

#Antibody discovery / biotechnology

Press coverage on a dermal microcoring device and clinical outcomes listed on the site.

#Dermatology / medical device

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.